Search

Inmode Ltd

Ouvert

SecteurSoins de santé

15.17 -1.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

14.96

Max

15.37

Chiffres clés

By Trading Economics

Revenu

-15M

12M

Ventes

-22M

82M

P/E

Moyenne du Secteur

11.37

68.51

BPA

0.25

Marge bénéficiaire

14.097

Employés

660

EBITDA

-17M

15M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+10.61% upside

Dividendes

By Acuity

Prochains Résultats

5 août 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-24M

882M

Ouverture précédente

16.28

Clôture précédente

15.17

Sentiment de l'Actualité

By Acuity

50%

50%

175 / 340 Classement par Healthcare

Inmode Ltd Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 juil. 2026, 18:56 UTC

Inmode Ltd shares are lower, influenced by declines in the Health Care Equipment sub-sector. The stock has traded lower since Wednesday's close.

29 juil. 2026, 19:55 UTC

Inmode Ltd shares are lower Wednesday, continuing a decline since Tuesday's close amid broader market pressure from rising crude oil prices and inflation concerns.

28 juil. 2026, 22:51 UTC

News

Inmode Ltd shares declined in after-market hours as Steel Partners urged shareholders to reject proposals, citing governance concerns and excessive compensation.

22 juil. 2026, 19:16 UTC

Inmode Ltd shares are lower amid rising crude oil prices and geopolitical tensions. No specific company news was identified to explain the decline.

21 juil. 2026, 15:46 UTC

Inmode Ltd shares are lower Tuesday, extending a decline after three consecutive daily closes. The stock opened with a notable dip before recovering slightly.

20 juil. 2026, 19:26 UTC

News

InMode Ltd faces scrutiny from Bronstein, Gewirtz & Grossman, LLC, over governance issues, contributing to a decline in its stock price since Friday's close.

Comparaison

Variation de prix

Inmode Ltd prévision

Objectif de Prix

By TipRanks

10.61% hausse

Prévisions sur 12 Mois

Moyen 17 USD  10.61%

Haut 19 USD

Bas 15 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

4

Maintien

0

Vente

Sentiment

By Acuity

175 / 340Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Inmode Ltd

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
help-icon Live chat